Probiotic use, flu-like symptoms, and your health.

Probiotic use, flu-like symptoms, and your health.

A recent study published in Frontiers in Pharmacology suggests that regular intake of probiotics can reduce the amount of acute respiratory tract infections (RTI’s) which may save the economy about 1.4 billion dollars yearly in lost productivity.

RTI’s cause mild to severe flu-like symptoms and are responsible for many doctors’ visits during flu season.

Probiotics are normally taken to improve gut health. It has been shown that healthy flora in the gut may be harmed by the intake of antibiotics.  When the flora changes in the gut, a person may gain weight, have inflammation in their body and may be subject to many common diseases treated by doctors.
Researchers need to study probiotics further and determine which strains are more or less effective.

In the future, perhaps probiotics may be a safer and healthier alternative to our current model of care which includes staying home, risking secondary infections and perhaps infecting others.

One other thing that is not mentioned in the article is the importance of proper breathing.  Few of us breathe deeply enough to get air into our lower lungs.  Deep breathing when you sense an infection may help abort bronchitis and a secondary infection if it is bacterial. Many of these organisms will grow in the lower lungs because there is a lack of oxygen. Deep breathing kills those bacteria. Try this the next time you have a cold and feel tightness in the chest. You may be surprised at how well it works

Check out the article below

Probiotic Use Can Lead To Major Economic And Health Savings Related To Flu-Like Illnesses

On Aug 28, 2019

An economic model estimates the impact of general probiotic use on acute respiratory tract infections in the US

A study published on August 27 in Frontiers in Pharmacology found that general probiotic use in the U.S. could save the health care payer and the economy around $1.4 billion in medical bills and lost productivity due to acute respiratory tract infections (RTIs).

RTIs include influenza-like illnesses (ILIs) with symptoms ranging from mild cold to the more serious flu. Although most acute RTI episodes resolve on their own, RTIs result in a high number of doctor visits and pose a heavy burden on society and the health care system.

The systematic reviews by York Health Economics Consortium (YHEC) and Cochrane Collaborative reported probiotics use was associated with reduced number and duration of ILIs, antibiotic courses used and days absent from work.

“We wanted to assess how much the use of probiotics in the management of common acute RTIs could contribute to savings in healthcare costs in the U.S.,” said Daniel Tancredi, co-author on the study, an associate professor at the Department of Pediatrics and a researcher at the Center for Healthcare Policy and Research at UC Davis.

Read more